Skip to main content

Health Insurance: Coverage of Autologous Bone Marrow Transplantation for Breast Cancer

HEHS-96-83 Published: Apr 24, 1996. Publicly Released: May 28, 1996.
Jump To:
Skip to Highlights

Highlights

Pursuant to a congressional request, GAO reviewed insurance coverage of autologous bone marrow transplantation (ABMT) for breast cancer, focusing on: (1) the factors insurers consider when deciding whether to cover treatment; (2) the effectiveness of the treatment; and (3) the consequences of the increased use and insurance coverage of the treatment while it is still in clinical trials.

Full Report

Office of Public Affairs

Topics

Breast cancerCancer researchChemotherapyHealth care cost controlHealth care servicesHealth insuranceHealth insurance cost controlHealth research programsMedicaidMedical services ratesMedicareRadiation exposure hazardsWomenOrgan and tissue transplantation